Skip to main content
OpenTrials

Clinical trial condition

Essential Hypertension

Explore clinical trials studying Essential Hypertension. Study availability and eligibility vary by location and protocol.

374 public trials 30 recruiting studies
Refine in advanced search Browse all conditions

Essential Hypertension trial results

Completed

A Long-term (12 Months) Safety, Tolerability and Efficacy Study of LCZ696 in Patients With Essential Hypertension

NCT01256411

Conditions
Cardiovascular Diseases, Essential Hypertension, Hypertension, +1 more
Locations
  • Novartis Investigative Site Chongqing, Chongqing Municipality, China
  • Novartis Investigative Site Shijiazhuang, Hebei, China
  • Novartis Investigative Site Hangzhou, Zhejiang, China
  • Novartis Investigative Site Beijing, China
View all 33 locations
View Trial Details
Completed

Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Japanese Patients With Essential Hypertension

NCT01599104

Conditions
Cardiovascular Diseases, Essential Hypertension, Hypertension, +1 more
Locations
  • Novartis Investigative Site Kamogawa, Chiba, Japan
  • Novartis Investigative Site Chikushi-gun, Fukuoka, Japan
  • Novartis Investigative Site Fukuoka, Japan
  • Novartis Investigative Site Fukuoka, Japan
View all 61 locations
View Trial Details
Completed

Safety and Efficacy of Aliskiren in Pediatric Hypertensive Patients 6-17 Years of Age

NCT01150357

Conditions
Cardiovascular Diseases, Essential Hypertension, Hypertension, +1 more
Locations
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site Little Rock, Arkansas, United States
  • Novartis Investigative Site Los Angeles, California, United States
  • Novartis Investigative Site San Diego, California, United States
View all 48 locations
View Trial Details
Completed

To Evaluate the Efficacy and Safety on Blood Pressure In Patients With Hypertension Diagnosed Congestive Heart Failure

NCT01682564

Conditions
Cardiovascular Diseases, Congestive Heart Failure, Essential Hypertension, +4 more
Locations
  • Inje university pusan hospital Busan, Busanjin-gu Gaegum-dong, South Korea
  • Gyeongsang national university hospital Jinju, Chiram-dong, South Korea
  • Daegu fatima hospital Daegu, Dong-gu Sinam-dong, South Korea
  • Daedong hospital Busan, Dongnae-gu Myeongnyun-dong, South Korea
View all 14 locations
View Trial Details

Related conditions